Table 4.
Adverse effects
| Clevidipine (n = 44) | Non-clevidipine (n = 53) | p-value | |
|---|---|---|---|
| Significant hypotension (sBP < 90 mmHg), n (%) | 0 (0%) | 3 (5,3%) | 0.06 |
| Significant bradycardia, n (%) | 0 (0%) | 0 (0%) | 1 |
| New atrial fibrillation, n (%) | 0 (0%) | 0 (0%) | 1 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.